Stock listing

ZA71 Stock Price, News, Filings & Events — Larimar Therapeutics, Inc.

Selected listing: ZA71 · GETTEX · EUR · DE

The selected listing for Larimar Therapeutics, Inc. is ZA71:GETTEX. The company focuses on developing innovative therapies for rare diseases, particularly targeting conditions related to mitochondrial dysfunction. Recent news highlights their ongoing clinical trials and advancements in their drug development pipeline. Investors can find relevant filings and updates on upcoming events that may impact the company's market position and future prospects.

ZA71:GETTEXEURDEUpdated July 24, 2026
Larimar Therapeutics, Inc. logo
Ticker
ZA71:GETTEX
Asset type
Stock
Market cap
$415.5M
Sector
Health Technology
Industry
Biotechnology
Exchange
GETTEX
Currency
EUR

Larimar Therapeutics, Inc. ZA71:GETTEX stock context

The selected listing for Larimar Therapeutics, Inc. is ZA71:GETTEX. The company focuses on developing innovative therapies for rare diseases, particularly targeting conditions related to mitochondrial dysfunction. Recent news highlights their ongoing clinical trials and advancements in their drug development pipeline. Investors can find relevant filings and updates on upcoming events that may impact the company's market position and future prospects.

Research Larimar Therapeutics, Inc.

Alternate listings